Table 2. ECMO Characteristics.
| Subject | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
| Pre-ECMO PaO2/FIO2 | 32 | 90 | 71 | 76 | 103 | 69 | 145 | 69 | 124 |
| Pre-ECMO ventilation days | 0.5 | 1 | 0.8 | 0.4 | 7 | 3 | 2 | 1 | 1 |
| Pre-transplant ECMO days | 5 | 1 | 0.5 | 1 | 8 | 7 | 3 | 14 | 11 |
| Approximate ECMO “rest” ventilator settings | |||||||||
| Mode | Continuous mandatory ventilation | Continuous mandatory ventilation | Continuous mandatory ventilation | Continuous mandatory ventilation | Tracheostomy collar | Support | Bi-level positive airway pressure | Tracheostomy collar | Mixed |
| Limit | Pressure | Pressure | Pressure | Pressure | ND | Pressure | Pressure | ND | Pressure |
| PIP | 30 | 18 | 18 | 36 | ND | 18 | 20 | ND | 23 |
| PEEP | 10 | 8 | 8 | 10 | ND | 6 | 8 | ND | 10 |
| FIO2 | 0.4 | 0.21 | 0.21 | 1.0 | 1.0 | 0.4 | 0.6 | 1.0 | 0.5 |
| Typical sedation infusions while on ECMO | Fentanyl 50 μg/h Midazolam 2 mg/h Dexmetomidate 0.5 μg/kg/h | Fentanyl 50 μg/h Lorazepam 2 mg/h Propofol 40 μg/kg/min | Fentanyl 150 μg/h Propofol 50 μg/kg/min | Fentanyl 100 μg/h Midazolam 2 mg/h | None | None | None | None | None |
| Rehabilitation | No | No | No | No | Yes | Yes | Yes | Yes | Yes |
ECMO = extracorporeal membrane oxygenation
ND = no data available